All posts by gerbonis

Benvenuti in questo sito

Benvenuti
In queste pagine troverete semplici ed utili informazioni su una tecnica diagnostica,l’Ecocardiografia Bidimensionale con Doppler e Color Doppler, in ambito Prenatale e Neonatale,che in questi ultimi 30 anni di utilizzo Specialistico, ha assunto un ruolo fondamentale nello screening prenatale e neonatale della malformazioni del cuore dal feto in formazione nell’utero materno. al bambino nei suoi primi mesi di vita.
Originariamente Cardiologo Clinico Ospedaliero , dal 1987 ad 2006 mi sono occupato di Cardiologia Perinatale come Responsabile di Unita’ Operativa Semplice di diagnostica EcocardioDoppler sia nel periodo Fetale che Neonatale e Pediatrico negli Ospedali dell’ASL di Chieti. In tale Specialita’ ho avuto incarichi di Docenza presso le scuole di Specializzazione di Cardiologia e Pediatria dell’Universita’ d’Annunzio di Chieti.
Attualmente continuo tale attivita’ nel mio studio in Pescara.
Questa pagina rappresenta il Portale di accesso al Mio Web Network

PERINATAL CARDIOLOGY

gerBlog

Queste pagine hanno finalita’ solamente informative per cui richiedono OBLIGATORIAMENTE il consulto dei relativi specialisti Cardiologo Pediatra e Ginecologo .
Buona lettura

Salvatore Gerboni Cardiologo
Iscrizione Ordine Provinciale dei Medici Chirurghi
di Pescara n.3169 del 20/03/1997

Vedi sulla Mappa
Viale Marconi 270 – Pescara

Contatti: Perinatal Cardiology

Share Button
More

Prenatal Evaluation and Management of Fetuses Exposed to Anti-SSA/Ro Antibodies

REVIEW ARTICLE
Pediatr Cardiol (2012) 33:1245–1252

Prenatal Evaluation and Management of Fetuses Exposed
to Anti-SSA/Ro Antibodies
Anita Krishnan Jodi I. Pike Mary T. Donofrio

Received: 23 February 2012 / Accepted: 29 April 2012 / Published online: 22 May 2012
Springer Science+Business Media, LLC 2012
Abstract
Maternal anti-SSA antibodies are common, existing in up to 2 % of the general population. Fetuses
exposed to these antibodies are at risk for both cardiac and noncardiac complications. The cardiac complications
include arrhythmias, structural disease, and cardiomyopathy. Although rare, the cardiac disease associated with these
antibodies is permanent and severe. Current fetal echocardiographic screening tools are nonspecific. The type and
frequency of screening needed is controversial. Although promising transplacental treatment strategies exist, pro-
spective randomized studies are lacking. Dexamethasone, the medication used most frequently, imposes significant
risks to both mother and fetus. This report presents a discussion of the at-risk population, the spectrum of fetal
cardiac disease associated with maternal anti-SSA antibodies, the current fetal echocardiographic screening tools,
the therapeutic options, and the management and delivery planning strategies. With appropriate prenatal follow-up,
assessment, and delivery planning, even high-risk fetuses can be delivered safely and managed effectively.

Pediatr Cardiol (2012) 33:1245–1252

Share Button
More

Echocardiographic observation and clinical significance of echogenic intracardiac foci in 310 fetuses

23rd World Congress on Ultrasound in Obstetrics and Gynecology

Echocardiographic observation and clinical significance
of echogenic intracardiac foci in 310 fetuses
Y. He, Y. Guo, Y. Zhang, J. Han, Z. Li
Beijing Anzhen Hospital Capital Medical University, Beijing,
China
Objectives:
To assess the clinical meaning of echogenic intracardiac
focus in fetuses by echocardiography.

Share Button
More

Echogenic focus in the fetal left ventricular cavity: Is it a false tendon?

neologoEchogenic focus in the fetal left ventricular cavity: Is it a false tendon?
Nahide Altug a*, A. Nuri Danisman b*
a* Zekai Tahir Burak Maternity Teaching Hospital, Ped. Cardiology Unit, Ankara, Turkey
b* Zekai Tahir Burak Maternity Teaching Hospital, Perinatology Unit, Ankara, Turkey

Early Human Development, Volume 89, Issue 7, July 2013, Pages 479-482

abstract

Keywords: Fetus, False tendon,Echogenic focus,Fetal echocardiography
Objective:
To draw attention to the left ventricular false tendon which can be misinterpreted as echogenic focus in the fetus.
Methods:
The study group consisted of 9 fetuses out of the 161 who had been misdiagnosed for left ventricular false tendon as echogenic focus by obstetricians. Fetal echocardiography and 2-D color Doppler echocardiography were performed in the pre-postnatal period. The standard fetal echocardiographic views (4,5 chamber views, long axis view of the left ventricle, short axis view of the ventricles and great arteries, three vessels and trachea view, long axis views of the duct and aortic arch) were obtained for each case.

Share Button
More

Echocardiographic observation and clinical significance of echogenic intracardiac foci

23rd World Congress on Ultrasound in Obstetrics and Gynecology

Echocardiographic observation and clinical significance
of echogenic intracardiac foci in 310 fetuses
Y. He, Y. Guo, Y. Zhang, J. Han, Z. Li
Beijing Anzhen Hospital Capital Medical University, Beijing,
China
Objectives:
To assess the clinical meaning of echogenic intracardiac
focus in fetuses by echocardiography.
Methods:
The data of 310 fetuses diagnosed as echogenic
intracardiac focus by echocardiography were reviewed. The
ultrasonic characters and clinical data were analysed.
Results:
310 fetuses were all nature pregnancies, and pregnancies
with high risk factors was 41 cases. The solitary EIF cases in left
ventricle were 263 (85% ). The solitary EIF cases in right ventricle
were 1 (3‰). The multiple EIF cases in left ventricle were 44 (14%).
The multiple EIF cases in both ventricles was 2 (6‰). The incidence
of congenital heart disease in the EIF group was 19‰ (6 cases) and
there was no significant difference between the EIF group and the
normal group. Down syndrome cases were 2 (6‰) both of them were
in the high risks group (elderly pregnant woman) 5 women stopped
pregnancy because of fetal malformation. Among the remaining
cases EIF gradually became pale, smaller or disappeared in 281cases
(92%) and 299 (96%) isolated EIF cases had a good clinical outcome
after birth.
Conclusions:
The isolated EIF in fetal heart without complicating
any other abnormalities has no significant clinical meaning. There
were no relationship between the isolated EIF fetal chromosome
abnormality and congenital heart disease

Share Button
More

XLIII Congresso Societa' Italiana Cardiologia Pediatrica

Presidenti del Congresso
Ornella Milanesi, Giovanni Stellin
Università di Padova

Share Button
More

48th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

It is our pleasure to invite you to the 48th Annual Meeting of the Association for European Paediatric and Congenital Cardiology, which will be held in Helsinki on 21-24 May 2014. We are pleased to organise the Annual Meeting for the second time in Helsinki after the 1966 AEPC meeting.

Share Button
More

Prenatal Evaluation and Management of Fetuses Exposed to Anti-SSA/Ro Antibodies

REVIEW ARTICLE
Pediatr Cardiol (2012) 33:1245–1252

Prenatal Evaluation and Management of Fetuses Exposed
to Anti-SSA/Ro Antibodies
Anita Krishnan Jodi I. Pike Mary T. Donofrio

Received: 23 February 2012 / Accepted: 29 April 2012 / Published online: 22 May 2012
Springer Science+Business Media, LLC 2012
Abstract
Maternal anti-SSA antibodies are common, existing in up to 2 % of the general population. Fetuses
exposed to these antibodies are at risk for both cardiac and noncardiac complications. The cardiac complications
include arrhythmias, structural disease, and cardiomyopathy. Although rare, the cardiac disease associated with these
antibodies is permanent and severe. Current fetal echocardiographic screening tools are nonspecific. The type and
frequency of screening needed is controversial. Although promising transplacental treatment strategies exist, pro-
spective randomized studies are lacking. Dexamethasone, the medication used most frequently, imposes significant
risks to both mother and fetus. This report presents a discussion of the at-risk population, the spectrum of fetal
cardiac disease associated with maternal anti-SSA antibodies, the current fetal echocardiographic screening tools,
the therapeutic options, and the management and delivery planning strategies. With appropriate prenatal follow-up,
assessment, and delivery planning, even high-risk fetuses can be delivered safely and managed effectively.

Pediatr Cardiol (2012) 33:1245–1252

Share Button
More